Our research finds that 37% of people with diabetes report poor quality sleep, and about half suffer from restless sleep or have trouble staying asleep.
This study provides real-world evidence on hypoglycemia prevalence, its effects on people, and the implications for HCP & diabetes manufacturers.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.